Role of Sostdc1 in skeletal biology and cancer

Sclerostin domain-containing protein-1 (Sostdc1) is a member of the sclerostin family and encodes a secreted 28–32 kDa protein with a cystine knot-like domain and two N-linked glycosylation sites. Sostdc1 functions as an antagonist to bone morphogenetic protein (BMP), mediating BMP signaling. It also interacts with LRP6, mediating LRP6 and Wnt signaling, thus regulating cellular proliferation, differentiation, and programmed cell death. Sostdc1 plays various roles in the skin, intestines, brain, lungs, kidneys, and vasculature. Deletion of Sostdc1 gene in mice resulted in supernumerary teeth and improved the loss of renal function in Alport syndrome. In the skeletal system, Sostdc1 is essential for bone metabolism, bone density maintenance, and fracture healing. Recently, Sostdc1 has been found to be closely related to the development and progression of multiple cancer types, including breast, renal, gastric, and thyroid cancers. This article summarises the role of Sostdc1 in skeletal biology and related cancers to provide a theoretical basis for the treatment of related diseases.

[1]  M. Brandi,et al.  Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders , 2022, Osteoporosis International.

[2]  H. Xin,et al.  SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β‐catenin pathway , 2022, Environmental toxicology.

[3]  J. Lee,et al.  USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction , 2022, Cell Death & Disease.

[4]  Zhiying Zhao,et al.  Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis , 2022, Biochemical Genetics.

[5]  H. Kwon,et al.  MSX1 Drives Tooth Morphogenesis Through Controlling Wnt Signaling Activity , 2022, Journal of dental research.

[6]  Ran Wang,et al.  Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney , 2022, The Journal of pathology.

[7]  R. Swaminathan,et al.  Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women , 2022, Scientific Reports.

[8]  Weihui Chen,et al.  Revitalizing mouse diphyodontic dentition formation by inhibiting the sonic hedgehog signaling pathway , 2021, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  Yueping Chen,et al.  Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head , 2021, Saudi Pharmaceutical Journal : SPJ.

[10]  W. Yue,et al.  Uterine Sensitization-Associated Gene-1 in the Progression of Kidney Diseases , 2021, Journal of immunology research.

[11]  Qian Liu,et al.  lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway , 2021, Cell cycle.

[12]  Y. Tabata,et al.  Anti–USAG-1 therapy for tooth regeneration through enhanced BMP signaling , 2021, Science Advances.

[13]  D. Pe’er,et al.  Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung , 2020, bioRxiv.

[14]  X. Bian,et al.  SOSTDC1-producing follicular helper T cells promote regulatory follicular T cell differentiation , 2020, Science.

[15]  J. Casal,et al.  SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166 , 2020, Oncogene.

[16]  Chandramohan Kattamuri,et al.  Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST , 2020, The Biochemical journal.

[17]  Faping Li,et al.  Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. , 2020, International immunopharmacology.

[18]  E. Cho,et al.  Suppression of Hedgehog signaling is required for cementum apposition , 2020, Scientific Reports.

[19]  G. Mortier,et al.  WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders , 2020, Frontiers in Endocrinology.

[20]  Aijie Chen,et al.  The Role of Tantalum Nanoparticles in Bone Regeneration Involves the BMP2/Smad4/Runx2 Signaling Pathway , 2020, International journal of nanomedicine.

[21]  S. Seno,et al.  In vivo dynamic analysis of BMP-2-induced ectopic bone formation , 2020, Scientific Reports.

[22]  K. Lam,et al.  The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling. , 2019, American journal of cancer research.

[23]  Cheng Ren,et al.  MiR-26a promotes fracture healing of nonunion rats possibly by targeting SOSTDC1 and further activating Wnt/β-catenin signaling pathway , 2019, Molecular and Cellular Biochemistry.

[24]  P. Croucher,et al.  Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells , 2019, Bone.

[25]  G. Loots,et al.  Sostdc1 Regulates NK Cell Maturation and Cytotoxicity , 2019, The Journal of Immunology.

[26]  J. O. Manilay,et al.  Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies , 2019, Current Osteoporosis Reports.

[27]  R. Krumlauf,et al.  Shh Plays an Inhibitory Role in Cusp Patterning by Regulation of Sostdc1 , 2018, Journal of dental research.

[28]  Jianru Xiao,et al.  SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target , 2018, International journal of molecular medicine.

[29]  Jiadong Wang,et al.  E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin , 2018, Cell Death & Disease.

[30]  B. Ozgul,et al.  Investigation of SOSTDC1 gene in non-syndromic patients with supernumerary teeth , 2018, Medicina oral, patologia oral y cirugia bucal.

[31]  M. Dixon,et al.  Ectopic Hedgehog Signaling Causes Cleft Palate and Defective Osteogenesis , 2018, Journal of dental research.

[32]  L. Hood,et al.  Population-specific genetic modification of Huntington's disease in Venezuela , 2018, PLoS genetics.

[33]  Wenbo Hao,et al.  Identification of methylation sites and signature genes with prognostic value for luminal breast cancer , 2018, BMC Cancer.

[34]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[35]  Jiadong Wang,et al.  SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways , 2017, Molecular and Cellular Biochemistry.

[36]  Motoko Yanagita,et al.  Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development , 2016, PloS one.

[37]  G. Loots,et al.  Sostdc1 deficiency accelerates fracture healing by promoting the expansion of periosteal mesenchymal stem cells. , 2016, Bone.

[38]  Katsu Takahashi,et al.  Effects of Usag-1 and Bmp7 deficiencies on murine tooth morphogenesis , 2016, BMC Developmental Biology.

[39]  H. Guan,et al.  SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation , 2016, Cell & Bioscience.

[40]  Vicki Rosen,et al.  BMP signalling in skeletal development, disease and repair , 2016, Nature Reviews Endocrinology.

[41]  L. Miller,et al.  Hepcidin regulation in prostate and its disruption in prostate cancer. , 2015, Cancer research.

[42]  Rajkumar Thangarajan,et al.  E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells , 2014, Cellular Oncology.

[43]  Yasuhiko Tabata,et al.  Interactions between BMP-7 and USAG-1 (Uterine Sensitization-Associated Gene-1) Regulate Supernumerary Organ Formations , 2014, PloS one.

[44]  R. Krumlauf,et al.  Wise Regulates Bone Deposition through Genetic Interactions with Lrp5 , 2014, PloS one.

[45]  G. Loots,et al.  Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner☆ , 2013, Developmental biology.

[46]  T. Rajkumar,et al.  SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. , 2013, Cancer genetics.

[47]  T. Mueller,et al.  Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling , 2013, PloS one.

[48]  Christof Niehrs,et al.  Secreted and transmembrane wnt inhibitors and activators. , 2013, Cold Spring Harbor perspectives in biology.

[49]  Jiake Xu,et al.  An overview of the regulation of bone remodelling at the cellular level. , 2012, Clinical biochemistry.

[50]  G. Seki,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13–USAG-1 pathway , 2012, Laboratory Investigation.

[51]  L. Miller,et al.  SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer , 2011, Breast Cancer Research and Treatment.

[52]  C. Tickle,et al.  Interactions between Shh, Sostdc1 and Wnt signaling and a new feedback loop for spatial patterning of the teeth , 2011, Development.

[53]  Zhenlin Zhang,et al.  Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men , 2011, Journal of Bone and Mineral Metabolism.

[54]  M. Willingham,et al.  Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors , 2010, Journal of experimental & clinical cancer research : CR.

[55]  R. Krumlauf,et al.  Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning , 2010, Development.

[56]  G. Loots,et al.  Genetic evidence that SOST inhibits WNT signaling in the limb. , 2010, Developmental biology.

[57]  T. Sakurai,et al.  Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. , 2010, The Journal of clinical investigation.

[58]  Y. Arai,et al.  Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor , 2009, Genes, chromosomes & cancer.

[59]  J. Saldanha,et al.  Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals* , 2009, The Journal of Biological Chemistry.

[60]  E. Järvinen,et al.  Tinkering with the inductive mesenchyme: Sostdc1 uncovers the role of dental mesenchyme in limiting tooth induction , 2009, Development.

[61]  M. Ota,et al.  Lrp4 Modulates Extracellular Integration of Cell Signaling Pathways in Development , 2008, PloS one.

[62]  Katsu Takahashi,et al.  Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. , 2008, Biochemical and biophysical research communications.

[63]  A. Murphy,et al.  Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. , 2008, Kidney international.

[64]  M. Willingham,et al.  A human bone morphogenetic protein antagonist is down-regulated in renal cancer. , 2007, Molecular biology of the cell.

[65]  Katsu Takahashi,et al.  Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation. , 2007, Biochemical and biophysical research communications.

[66]  Scott Saunders,et al.  Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[68]  G. Beaudoin,et al.  Hairless triggers reactivation of hair growth by promoting Wnt signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Nobuyuki Itoh,et al.  Regulation of Mammalian Tooth Cusp Patterning by Ectodin , 2005, Science.

[70]  Xi He,et al.  SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.

[71]  M. Yanagita BMP antagonists: their roles in development and involvement in pathophysiology. , 2005, Cytokine & growth factor reviews.

[72]  R. Baron,et al.  Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway* , 2005, Journal of Biological Chemistry.

[73]  M. Katoh,et al.  Identification and characterization of human CKTSF1B2 and CKTSF1B3 genes in silico. , 2004, Oncology reports.

[74]  A. Niida,et al.  USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. , 2004, Biochemical and biophysical research communications.

[75]  Nobuyuki Itoh,et al.  Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. , 2003, Developmental biology.

[76]  Hyo-Sang Park,et al.  BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. , 2003, Biochemical and biophysical research communications.

[77]  Alison Rowe,et al.  Wise, a context-dependent activator and inhibitor of Wnt signalling , 2003, Development.

[78]  Jae-Hyun Sung,et al.  BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression* , 2003, Journal of Biological Chemistry.

[79]  Nobuyuki Itoh,et al.  Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity* , 2003, Journal of Biological Chemistry.

[80]  D. Simmons,et al.  Uterine Sensitization-Associated Gene-1: A Novel Gene Induced Within the Rat Endometrium at the Time of Uterine Receptivity/Sensitization for the Decidual Cell Reaction1 , 2002, Biology of reproduction.

[81]  Jeffrey R. Miller,et al.  The Wnts , 2001, Genome Biology.

[82]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[83]  S. Khosla,et al.  Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women. , 2014, The Journal of clinical endocrinology and metabolism.

[84]  R. Atit,et al.  Wnt/β-catenin signaling directs multiple stages of tooth morphogenesis , 2008 .

[85]  O. Avsian-Kretchmer,et al.  Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. , 2004, Molecular endocrinology.